Soligenix’s Topical Photodynamic Therapy Receives Promising Innovative Medicine Designation in UK
News
Soligenix‘s investigational photodynamic therapy, SGX301, which uses a photosensitizer activated by safe visible fluorescent light, has been designated Promising Innovative Medicine (PIM) for the treatment of cutaneous T-cell lymphoma (CTCL). The ... Read more